EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer

Julien Corné iD, Véronique Quillien, Florence Godey, Mathilde Cherel, Agathe Cochet, Fanny Le Du, Lucie Robert, Héloïse Bourien, Angélique Brunot, Laurence Crouzet, Christophe Perrin, Claudia Lefeuvre-Plesse und 2 weitere

Molecular Oncology · 2024

DOI: 10.1002/1878-0261.13592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2024. Verfasst von Julien Corné und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Centre Eugène Marquis, Unicancer, Rennes, France. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms, Mutation, Neoplasm Metastasis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seagen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erb‐b2 receptor tyrosine kinase 2 ( ERBB2 )‐activating mutations are therapeutically actionable alterations found in various cancers, including metastatic breast cancer (MBC). We developed multiplex digital PCR assays to detect and quantify ERBB2 mutations in circulating tumor DNA from liquid biopsies. We studied the plasma from 272 patients with hormone‐receptor‐positive, human epidermal growth factor receptor 2‐negative (HR+/HER2−) MBC to detect 17 ERBB2 mutations using a screening assay. The assay was developed on the three‐color Crystal dPCR™ naica® platform with a two‐step strategy for precise mutation identification. We found that nine patients (3.3%) harbored at least one ERBB2 mutation. The mutation rate was higher in patients with lobular histology (5.9%) compared to invasive breast carcinoma of no special type (2.6%). A total of 12 mutations were found with the following frequencies: L755S (25.00%), V777L (25.00%), S310Y (16.67%), L869R (16.67%), S310F (8.33%), and D769H (8.33%). Matched tumor samples from six patients identified the same mutations with an 83% concordance rate. In summary, our highly sensitive multiplex digital PCR assays are well suited for plasma‐based monitoring of ERBB2 mutational status in patients with MBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesBreast NeoplasmsMutationNeoplasm MetastasisMultiplex Polymerase Chain ReactionHumansFemaleMiddle AgedAgedAdultDNA Mutational AnalysisCirculating Tumor DNAAged, 80 and over

Stichwörter der Autor:innen

ERBB2circulating tumor DNAliquid biopsiesmetastatic breast cancermultiplex digital PCRplasma

Substanzen

Erb-b2 Receptor Tyrosine KinasesCirculating Tumor DNAERBB2 protein, human

Autor:innen und Institutionen

  • Department of Biology, Centre Eugène Marquis, Unicancer, Rennes, France.
  • Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.
  • INSERM U1242, University of Rennes, France.

ORCID-Profile: Julien Corné

Förderung

  • Seagen

Zitieren

APA

Corné, J., Quillien, V., Godey, F., Cherel, M., Cochet, A., Le Du, F., Robert, L., Bourien, H., Brunot, A., Crouzet, L., Perrin, C., Lefeuvre-Plesse, C., Diéras, V., & De la Motte Rouge, T. (2024). Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer. Molecular Oncology. https://doi.org/10.1002/1878-0261.13592

Vancouver

Corné J, Quillien V, Godey F, Cherel M, Cochet A, Le Du F, et al. Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer. Molecular Oncology. 2024. doi:10.1002/1878-0261.13592

BibTeX
@article{Corn2024,
  author = {Corné, Julien and Quillien, Véronique and Godey, Florence and Cherel, Mathilde and Cochet, Agathe and Le Du, Fanny and Robert, Lucie and Bourien, Héloïse and Brunot, Angélique and Crouzet, Laurence and Perrin, Christophe and Lefeuvre-Plesse, Claudia and Diéras, Véronique and De la Motte Rouge, Thibault},
  title = {Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer},
  journal = {Molecular Oncology},
  year = {2024},
  doi = {10.1002/1878-0261.13592}
}
Kostenlos starten →